Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2025-12-26 @ 10:44 PM
Study NCT ID:
NCT00269412
Status:
COMPLETED
Last Update Posted:
2019-11-25
First Post:
2005-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
Sponsor:
Bausch Health Americas, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2007-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-22
First Submit QC Date:
None
Study First Post Date:
2005-12-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-21
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL